Patients with T1a-T2a invasive melanoma treated with Mohs micrographic surgery (MMS) at academic and higher case volume facilities have better overall survival than patients treated at nonacademic and low-volume facilities. A US study of over 4,000 patients treated at 462 centres reported 417 deaths during the ten-year study period. Survival at academic centres was 95.3% ...
Questions raised about outcomes with Mohs surgery for melanoma
By Mardi Chapman
14 Apr 2021